Interaction of schizophrenia and chronic cannabis use on reward anticipation sensitivity.


Journal

NPJ schizophrenia
ISSN: 2334-265X
Titre abrégé: NPJ Schizophr
Pays: United States
ID NLM: 101657919

Informations de publication

Date de publication:
16 Jun 2021
Historique:
received: 11 01 2021
accepted: 28 04 2021
entrez: 17 6 2021
pubmed: 18 6 2021
medline: 18 6 2021
Statut: epublish

Résumé

Chronic cannabis use and schizophrenia are both thought to affect reward processing. While behavioural and neural effects on reward processing have been investigated in both conditions, their interaction has not been studied, although chronic cannabis use is common among these patients. In the present study eighty-nine participants divided into four groups (control chronic cannabis users and non-users; schizophrenia patient cannabis users and non-users) performed a two-choice decision task, preceded by monetary cues (high/low reward/punishment or neutral), while being scanned using functional magnetic resonance imaging. Reward and punishment anticipation resulted in activation of regions of interest including the thalamus, striatum, amygdala and insula. Chronic cannabis use and schizophrenia had opposing effects on reward anticipation sensitivity. More specifically control users and patient non-users showed faster behavioural responses and increased activity in anterior/posterior insula for high magnitude cues compared to control non-users and patient users. The same interaction pattern was observed in the activation of the right thalamus for reward versus punishment cues. This study provided evidence for interaction of chronic cannabis use and schizophrenia on reward processing and highlights the need for future research addressing the significance of this interaction for the pathophysiology of these conditions and its clinical consequences.

Identifiants

pubmed: 34135344
doi: 10.1038/s41537-021-00163-2
pii: 10.1038/s41537-021-00163-2
pmc: PMC8209034
doi:

Types de publication

Journal Article

Langues

eng

Pagination

33

Subventions

Organisme : State Scholarships Foundation (IKY)
ID : 1425
Organisme : State Scholarships Foundation (IKY)
ID : 5033021

Références

Drug Alcohol Depend. 2011 Apr 1;114(2-3):242-5
pubmed: 21050680
Schizophr Res. 2010 Nov;123(2-3):93-104
pubmed: 20832997
Schizophr Bull. 2016 Sep;42(5):1262-9
pubmed: 26884547
Psychopharmacology (Berl). 2009 Sep;206(1):121-32
pubmed: 19521678
Eur Neuropsychopharmacol. 2010 Mar;20(3):153-63
pubmed: 20061126
Eur Addict Res. 2015;21(6):307-14
pubmed: 26022857
Psychiatry Res. 2011 Dec 30;194(3):263-270
pubmed: 22079658
Schizophr Res. 2014 Sep;158(1-3):176-82
pubmed: 25037524
Neurosci Biobehav Rev. 2011 Apr;35(5):1219-36
pubmed: 21185861
Schizophr Res. 2010 May;118(1-3):154-61
pubmed: 20005675
Front Behav Neurosci. 2009 Aug 27;3:21
pubmed: 19753142
Schizophr Res Treatment. 2013;2013:543842
pubmed: 23970971
Front Neurosci. 2016 Nov 10;10:515
pubmed: 27891073
PLoS One. 2018 Jun 18;13(6):e0198215
pubmed: 29912880
Schizophr Res. 2011 May;128(1-3):111-6
pubmed: 21420282
Neuroimage. 2013 Feb 1;66:508-21
pubmed: 23069809
Biol Psychiatry. 2013 Sep 15;74(6):467-74
pubmed: 23623456
Psychiatry Res. 2013 Oct 30;214(1):24-32
pubmed: 23906663
Schizophr Bull. 2014 Nov;40(6):1509-17
pubmed: 24345517
Psychol Med. 2015 Jun;45(8):1765-78
pubmed: 25577954
Schizophr Bull. 2018 Jan 13;44(1):147-157
pubmed: 27798223
Neuroimage. 2010 Jan 1;49(1):1133-43
pubmed: 19631753
PLoS One. 2013 May 15;8(5):e61470
pubmed: 23690923
Magn Reson Med. 1995 May;33(5):636-47
pubmed: 7596267
Hum Brain Mapp. 2018 Aug;39(8):3398-3418
pubmed: 29696725
PLoS One. 2014 Mar 07;9(3):e91008
pubmed: 24608867
Neuroimage Clin. 2019;23:101853
pubmed: 31096180
Schizophr Res. 2008 Mar;100(1-3):242-51
pubmed: 17614260
J Psychopharmacol. 2014 Jul;28(7):633-42
pubmed: 24646809
Proc Natl Acad Sci U S A. 2020 Jun 30;117(26):15200-15208
pubmed: 32527855
Schizophr Res. 2018 May;195:215-221
pubmed: 28867519
BMJ. 2002 Nov 23;325(7374):1199
pubmed: 12446534
Neuropsychopharmacology. 2014 Sep;39(10):2288-98
pubmed: 24705568
Soc Cogn Affect Neurosci. 2015 May;10(5):752-9
pubmed: 25193949
J Psychiatry Neurosci. 2016 Apr;41(3):152-61
pubmed: 26395814
Cereb Cortex. 2011 Jul;21(7):1498-506
pubmed: 21097516
Trends Neurosci. 2003 Sep;26(9):507-13
pubmed: 12948663
Psychopharmacology (Berl). 2008 Mar;196(4):673-84
pubmed: 18097655
Biol Psychiatry. 2012 May 15;71(10):898-905
pubmed: 22418013
Transl Psychiatry. 2019 Aug 22;9(1):203
pubmed: 31439831
PLoS One. 2015 Mar 23;10(3):e0119150
pubmed: 25799565
Soc Cogn Affect Neurosci. 2009 Jun;4(2):208-13
pubmed: 19470529
Neuroimage. 2006 Jan 15;29(2):409-16
pubmed: 16139525
Hum Brain Mapp. 1996;4(1):58-73
pubmed: 20408186
Neuropsychopharmacology. 2010 Nov;35(12):2427-39
pubmed: 20720534
Schizophr Bull. 2012 Mar;38(2):316-30
pubmed: 20660494
Brain Struct Funct. 2010 Jun;214(5-6):645-53
pubmed: 20512378
Soc Cogn Affect Neurosci. 2009 Dec;4(4):417-22
pubmed: 20042432
Psychopharmacology (Berl). 2006 Aug;187(2):222-8
pubmed: 16721614
Dev Cogn Neurosci. 2015 Dec;16:5-15
pubmed: 26070843
Front Behav Neurosci. 2014 Nov 18;8:382
pubmed: 25477792
J Psychopharmacol. 2018 Aug;32(8):825-849
pubmed: 29591635
Schizophr Bull. 2010 Nov;36(6):1115-30
pubmed: 19386576

Auteurs

Simon Fish (S)

Laboratory of Cognitive Neuroscience and Sensorimotor Control, University Mental Health, Neurosciences and Precision Medicine Research Institute "COSTAS STEFANIS", Athens, Greece.
1st Department of Psychiatry, National and Kapodistrian University of Athens, School of Medicine, Eginition Hospital, Athens, Greece.

Foteini Christidi (F)

Department of Medical Physics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.

Efstratios Karavasilis (E)

2nd Department of Radiology, National and Kapodistrian University of Athens, School of Medicine, University General Hospital "ATTIKON", Athens, Greece.

Georgios Velonakis (G)

2nd Department of Radiology, National and Kapodistrian University of Athens, School of Medicine, University General Hospital "ATTIKON", Athens, Greece.

Nikolaos Kelekis (N)

2nd Department of Radiology, National and Kapodistrian University of Athens, School of Medicine, University General Hospital "ATTIKON", Athens, Greece.

Christoph Klein (C)

2nd Department of Psychiatry, National and Kapodistrian University of Athens, School of Medicine, University General Hospital "ATTIKON", Athens, Greece.
Department of Child and Adolescent Psychiatry, Medical Faculty, University of Freiburg, Freiburg, Germany.
Department of Child and Adolescent Psychiatry, Medical Faculty, University of Cologne, Cologne, Germany.

Nicholas C Stefanis (NC)

1st Department of Psychiatry, National and Kapodistrian University of Athens, School of Medicine, Eginition Hospital, Athens, Greece.

Nikolaos Smyrnis (N)

Laboratory of Cognitive Neuroscience and Sensorimotor Control, University Mental Health, Neurosciences and Precision Medicine Research Institute "COSTAS STEFANIS", Athens, Greece. smyrnis@med.uoa.gr.
2nd Department of Psychiatry, National and Kapodistrian University of Athens, School of Medicine, University General Hospital "ATTIKON", Athens, Greece. smyrnis@med.uoa.gr.

Classifications MeSH